The human fatty-acid synthase (HFAS) is a potential target for anti-tumor drug discovery. As a prelude to the design of compounds that target the enoyl reductase (ER) component of HFAS, the recognition of NADPH and exogenous substrates by the ER active site has been investigated. Previous studies demonstrate that modification of Lys-1699 by pyridoxal 5-phosphate results in a specific decrease in ER activity. For the overall HFAS reaction, the K1699A and K1699Q mutations reduced k cat and k cat /K NADPH by 8-and 600-fold, respectively (where K NADPH indicates the K m value for NADPH). Thus, Lys-1699 contributes 4 kcal/mol to stabilization of the rate-limiting transition state following NADPH binding, while also stabilizing the most stable ground state after NADPH binding by 3 kcal/mol. A similar effect of the mutations on the ER partial reaction was observed, in agreement with the proposal that Lys-1699 is located in the ER NADPH-binding site. Most unexpectedly, however, both k cat and k cat /K NADPH for the ␤-ketoacyl reductase (BKR) reaction were also impacted by the Lys-1699 mutations, raising the possibility that the ER and BKR activities share a single active site. However, based on previous data indicating that the two reductase activities utilize distinct cofactor binding sites, mutagenesis of Lys-1699 is hypothesized to modulate BKR activity via allosteric effects between the ER and BKR NADPH sites.
tumors, and also in many pre-malignant growths, has led to the hypothesis that HFAS is an important target for the study of tumor biology (7, 13, 14) .
Our laboratory has a long standing interest in the development of antibacterial compounds that target prokaryotic fatty acid synthesis. Thus, an initial interest in HFAS was as a control system for validating the specificity of our bacterial FAS inhibitors. However, as described above, HFAS is now thought to be a bona fide target in its own right as a putative anti-tumor target. There have also been suggestions that HFAS inhibitors might provide some therapeutic benefit in the control of obesity (15) (16) (17) . Initial reports on the anti-tumor activity of HFAS inhibitors focused on compounds that target the ␤-ketoacyl synthase activity, such as cerulenin and C75 (14) . More recently, Anderson and co-workers (18) have reported that triclosan, an antibacterial additive in many personal care products, inhibited the enoyl reductase activity of HFAS with an IC 50 value of 50 M and also prevented the growth of a breast cancer cell line at a similar concentration. In order to provide information relevant to the design of compounds that target the ER component of HFAS, we have performed a detailed kinetic analysis of the overall and partial reactions catalyzed by HFAS. These studies have been extended to include mutants of Lys-1699, a residue that is modified by pyridoxal 5Ј-phosphate (PLP). Lys-1699 is part of a characteristic SXXK motif found in PLP-dependent enzymes (19) . Although mammalian FAS does not require PLP, the site-specific incorporation of PLP was used to show that Lys-1699 is located close to the ER active site in the goose and chicken FAS enzymes (2, 19 -21) . In order to explore the role of Lys-1699 in more detail, we used site-directed mutagenesis to alter Lys-1699, and we carried out detailed kinetic experiments to determine the effect of these mutations on the overall and partial reactions catalyzed by HFAS. For the overall HFAS reaction, these studies reveal that Lys-1699 stabilizes the rate-limiting transition state following NADPH binding by 4 kcal/mol and also stabilizes the ground state to which NADPH binds by 3 kcal/mol. Lys-1699 also makes similar contributions to ground and transition state stabilization in the ER reaction, as expected from the PLP labeling studies. However, unexpectedly the BKR reaction is also affected by mutation of Lys-1699. By analogy to the short chain dehydrogenase/reductase (SDR) family, a likely mechanism by which Lys-1699 acts is via direct interactions with NADPH in the ER cofactor binding site. A similar role can be envisaged for Lys-1699 in the BKR reaction, if both BKR and ER activities are catalyzed by a single active site. Alternatively, if the BKR and ER enzymes utilize separate cofactor binding sites, then modulation of the BKR reaction through interaction of NADPH with Lys-1699 must occur through allosteric effects between the two binding sites.
In the course of kinetic experiments to determine k cat and K m values for the overall HFAS reaction as well as each individual component, we noted that k cat for the reduction of crotonyl-CoA was lower than the value obtained for the overall reaction. In order to explore the role of the intrinsic ACP moiety in the interaction of exogenously added substrates with HFAS, we mutated Ser-2151, the point of pantetheine attachment, to HFAS (22, 23) , and we investigated the chain length specificity of the enzyme toward exogenously added enoyl reductase substrates.
EXPERIMENTAL PROCEDURES
Materials-A pFastBac1 clone containing the cDNA coding for the entire HFAS protein with a C-terminal His tag was a generous gift from GlaxoSmithKline. Oligonucleotides were from Integrated DNA Technologies (Coralville, IA). Pfu polymerase, the BAC-to-BAC baculovirus expression system, Escherichia coli maximum efficiency DH10 Bac competent cells, and Spodoptera frugiperda (Sf9) insect cells were obtained from Invitrogen. pBluescript and E. coli XL-1 Blue competent cells were from Stratagene (La Jolla, CA), and the AatII, MluI, HindIII, EcoRI, and BamHI restriction enzymes were from New England Biolabs (Beverly, MA). ABI Prism Big Dye Terminator Cycle Sequencing was carried out on an MJ Research PTC-100 Programmable Thermal Controller from Global Medical Instrumentation, Inc. (Ramsey, MN). The DNA Sequencing Facility at Stony Brook University provided the ABI BigDye reaction mix. The NADPH, CoA lithium salt, ethyl chloroformate, triethylamine, 2-octenoic acid (predominantly trans), and crotonyl-CoA were purchased from Sigma, and the His-Bind resin was from Novagen (Madison, WI). Amersham Biosciences provided the Sephadex G-25 (fine) resin and the chromatography columns, and the 10% Tris-glycine gels were purchased from Bio-Rad. Dialysis membrane, all buffer reagents, and solvents were purchased from Fisher. 2-trans-Dodecenoic acid was purchased from TCI Chemicals.
Construction of the K1699A, K1699Q, and S2151A Mutants-Mutagenesis on the original HFAS insert and vector was problematic because of the large size of this construct (13 kb). Consequently, sitedirected mutagenesis was performed on a portion of the HFAS cDNA containing the target site for mutagenesis that had been subcloned into pBluescript (3 kb). For the K1699A and K1699Q mutants, EcoRI and HindIII restriction sites were initially used to remove a portion of the HFAS cDNA from pFastBac1 and to insert this segment into pBluescript KS. Following site-directed mutagenesis, the MluI and AatII restriction sites were used to remove a segment of the HFAS cDNA encompassing the site of mutation from pBluescript KS. The pFastBacI vector containing the mutant HFAS cDNA was then generated by three-way ligation. This involved ligating the MluI/AatII DNA fragment to pFastBac1 that had been digested with MluI and HindIII, together with a second DNA fragment generated from HFAS-pFastBacI using the AatII and HindIII sites. The S2151A mutant was generated using a similar protocol using BamHI and HindIII restriction sites to transfer the relevant HFAS cDNA between pFastBacI and pBluescript. The primers used for the mutagenesis are given in TABLE ONE.
Expression and Purification of Wild-type and Mutant HFAS Proteins-The pFastBac1 constructs were utilized to produce recombinant baculoviral stocks by the transposition procedure of the BAC-to-BAC baculovirus expression system. Sf9 cells were transfected with recombinant bacmid DNA, and virus was harvested from cell culture medium at 72 h post-transfection. Each viral stock was subjected to two rounds of amplification after which the viral titer was determined. Sf9 cells were infected with recombinant baculovirus, and a cell pellet was collected 72 h post-infection. The pellet was resuspended in 15-30 ml of His-bind buffer (5 mM imidazole, 0.5 M NaCl, and 20 mM Tris-HCl, pH 7.9) and lysed by French press (5 times at 1000 p.s.i.). The cell lysate was then centrifuged at 33,000 rpm for 90 min, and the supernatant was filtered with a 0.45-m Millipore filter and applied to a His-bind resin column (5-ml bed volume). The His-bind column was washed with His-bind buffer and then with wash buffer (60 mM imidazole, 0.5 M NaCl, and 20 mM Tris-HCl, pH 7.9). Protein elution was performed using a gradient of 5 mM to 1 M imidazole in 20 mM Tris-HCl and 0.5 M NaCl. Fractions containing wild-type or mutant HFAS proteins were then immediately chromatographed on a Sephadex G-25 column, equilibrated with 0.8 M KH 2 PO 4 , 1 mM EDTA, pH 7.4. The protein was dialyzed into 0.8 M KH 2 PO 4 , pH 7.4, buffer containing 1 mM EDTA, and 10 mM dithiothreitol using molecular porous membrane tubing. Subsequently, 100 -200-l aliquots of protein were snap-frozen in liquid nitrogen with 20% glycerol for storage at Ϫ80°C. Protein expression and purification were analyzed by SDS-PAGE on 10% Tris-glycine gels. Protein concentration was determined by the absorbance at 280 nm using an extinction coefficient (⑀ 280 ) of 279650 M Ϫ1 cm Ϫ1 calculated at Expasy (www.expasy.ch)
by assuming one active site per monomer. Protein yield was assessed using the calculated molecular mass of 273 kDa (www.expasy.ch). Synthesis of 2-Octenoyl-CoA and 2-Dodecenoyl-CoA-2-OctenoylCoA (C 8 -CoA) and 2-dodecenoyl-CoA (C 12 -CoA) were synthesized from the respective acids using the mixed anhydride method (24, 25) . 300 mg (1.5 mmol) of trans-2-dodecenoic acid was dissolved slowly in 2 ml of anhydrous tetrahydrofuran (THF) and then placed in a flask that had been purged with nitrogen gas. 210 mg (2.1 mmol) of anhydrous triethylamine in 1 ml of THF was added slowly to the flask followed by 386 mg (3.6 mmol) of ethylchloroformate in 1 ml of THF, which resulted in the formation of a white precipitate. An additional 2 ml of THF was added, and then the reaction mixture was stirred overnight at room temperature. 750 l of the mixed anhydride was filtered with glass wool in a Pasteur pipette, and 500 l of the filtrate was added dropwise with stirring to 30 mg of CoA dissolved in 1 ml of 50 mM Na 2 CO 3 at room temperature. The reaction was monitored by evaluating the amount of free thiol in solution using 5,5Ј-dithiobis(2-nitrobenzoic acid) (26) . When no more free thiol was present, the reaction mixture was immediately purified by high pressure liquid chromatography (Shimadzu), using a Phenomenex C 18 -preparative column. Purification was performed with 20 mM ammonium acetate, 1.75% acetonitrile (Buffer A) with a 0 -100% gradient of 95% acetonitrile, 5% H 2 O (Buffer B) for 90 min and a flow rate of 4 ml/min. Chromatography was monitored at 260 and 280 nm with a Shimadzu SPD-10A UV-visible detector, and the retention time for C 12 -CoA was 35-40 min. Fractions containing C 12 -CoA were combined, lyophilized, re-dissolved in 500 l of H 2 O, and re-lyophilized to remove all ammonium acetate. The C 12 -CoA was then 
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Kinetic Analysis of the Overall HFAS Reaction and HFAS Partial
Activities-Specific activities for the overall HFAS reaction were determined at 25°C in 500 l of assay buffer (0.1 M KH 2 PO 4 , 1 mM EDTA, pH 7.0) using 100 M NADPH, 20 nM wild-type HFAS or 80 -160 nM mutant HFAS, 25 M acetyl-CoA, and 100 M malonyl-CoA. The rate of the reaction was determined by monitoring the decrease in NADPH absorbance at 340 nm, and initial velocities were calculated using an extinction coefficient (⑀ 340 ) of 6,300 M Ϫ1 cm Ϫ1 . Partial activities were determined using a similar protocol in the same assay buffer. ER activity was determined using 100 M NADPH, 80 nM HFAS or 160 nM mutant HFAS, and 100 M crotonyl-CoA, whereas BKR activity was determined using 100 M NADPH, 20 nM wild-type HFAS or 160 nM mutant HFAS, and 100 M acetoacetyl-CoA. DH activity was determined by monitoring the hydration of crotonyl-CoA at 280 nm using 80 nM HFAS and 100 M substrate. An extinction coefficient (⑀ 280 ) of 3600 M Ϫ1 cm Ϫ1 was used for the conversion of crotonyl-CoA into 3-hydroxybutyryl-CoA. The above assay conditions were also used for the determination of k cat and K m values. For the overall HFAS reaction, K NADPH was determined by using 100 M malonyl-CoA and 25 M acetyl-CoA and by varying the NADPH concentration from 5 to 100 M for wild-type and from 80 to 800 M for the mutant enzymes. Determination of K NADPH for the mutant enzymes was performed by monitoring NADPH oxidation at 370 nm due to the high concentration of NADPH and by using an extinction coefficient of 2400 M Ϫ1 cm Ϫ1 (27) . Similarly, K MAL (where Interaction of NADPH with HFAS Monitored by Fluorescence Spectroscopy-NADPH binding to HFAS was analyzed at 25°C using a Spex Fluorolog 3 spectrofluorimeter. NADPH fluorescence was excited at 340 nm (5 nm slit width) and monitored between 400 and 500 nm (1 nm slit width). 1-l aliquots of 0.3 mM NADPH were added to a cuvette containing 0.5 M wild-type or mutant HFAS enzymes in 0.1 M KH 2 P0 4 , 1 mM EDTA, pH 7 buffer. The NADPH concentration ranged from 0 to 20 M.
RESULTS
Expression and Purification of Wild-type and Mutant HFAS En-
zymes-500 ml of Sf9 insect cell culture yielded 5 mg of soluble wildtype HFAS that was Ͼ95% pure as judged by SDS-PAGE. Similar quantities of the K1699Q, K1699A, and S2151A mutant proteins were also obtained. Specific activities of the overall and partial reactions catalyzed by HFAS are given for the wild-type and mutant enzymes in TABLE TWO. Wild-type HFAS had a specific activity of 440 nmol/min/mg for the overall reaction. This value, together with those for the other partial activities catalyzed by the enzyme, were in good agreement with previously published data apart from the BKR activity that was ϳ7-10-fold lower (3). Replacement of Lys-1699 with Ala or Gln resulted in about a 10-fold decrease in specific activity for the overall reaction (TABLE  TWO) . In contrast, the S2151A mutant was completely inactive in all assays. To shed more light on the impact of the mutagenesis on the 
Kinetic Analysis of Wild-type HFAS as a Function of Substrate Chain
Length-A primary goal of the kinetic experiments was to establish assays for assessing the interaction of inhibitors with the different HFAS active sites. As noted above, k cat for the reduction of crotonyl-CoA by HFAS was around 8-fold slower than the corresponding value for the overall reaction. To explore whether alteration in substrate chain length resulted in an ER substrate that more closely mirrored the reduction of substrates when covalently attached to HFAS, we synthesized octenoylCoA (C 8 -CoA) and dodecenoyl-CoA (C 12 -CoA). However, comparison of the kinetic parameters for C 8 -CoA and C 12 -CoA with those obtained for Crt-CoA (TABLE FOUR) clearly show that the increase in substrate chain length results in a less optimal substrate for analyzing the ER partial reaction.
NADPH Binding to Wild-type and Mutant HFAS Enzymes-In order to assess the direct impact of the Lys-1699 mutations on the affinity of NADPH for HFAS, we attempted to use the change in NADPH fluorescence on binding to determine K d values for wild-type and mutant HFAS enzymes. NADPH fluorescence was excited at 340 nm and monitored between 400 and 500 nm. In each case the addition of NADPH to the enzyme solutions resulted in a linear increase in fluorescence up to 
DISCUSSION
It has been hypothesized that HFAS is a target for anti-cancer drug discovery. In order to direct inhibitor design, methods need to be available to quantitate the affinity of inhibitors for the enzyme. Because the enzyme could be inhibited by blocking any of the active sites in the multienzyme complex, we need to be able to assess inhibition of each individual partial activity. Although IC 50 measurements are useful for evaluating the potency of a series of inhibitors under identical conditions, K i values are needed in order to provide information about the mechanism of inhibition. Because K i values are determined by obtaining the apparent values of V max and K m at different inhibitor concentrations, we set out first to determine k cat and K m values for the overall HFAS reaction as well as each individual partial activity. More importantly, these studies were focused on the human fatty-acid synthase, a mammalian FAS that has been less extensively studied than the FAS enzymes from other sources such as chicken, rat, or goose. In addition, although there is no high resolution structural data for a mammalian FAS, our studies are also focused on supplementing published information on residues important for catalysis.
Kinetic Parameters for the Overall and Partial HFAS ActivitiesMethods for assaying the partial HFAS reactions involve the addition of exogenous substrates to the enzyme. Ideally, these reactions would closely mimic the reaction catalyzed by each active site during the overall chain elongation reaction. In this situation we would predict that k cat value for the partial reaction would be similar to, or greater than, the k cat value for the overall HFAS reaction of 160 min Ϫ1 . Perusal of TABLE THREE reveals that k cat value for the reduction of acetoacetyl-CoA by HFAS, which is an assay for the BKR reaction, is indeed greater than 160 min Ϫ1 . However, the k cat values for the DH and ER activities are significantly less than the k cat value for the overall reaction. For the DH activity we are actually monitoring the DH reaction in reverse (i.e. substrate hydration and not dehydration). This reaction will compete with the ER active site for crotonyl-CoA, thereby reducing the ER k cat value. Both the ER and DH activities have similar K m values for crotonyl-CoA, and we note that the k cat value for DH is 3-fold lower (6 min Ϫ1 ) than that for ER (20 min Ϫ1 ). By assuming that the binding of NADPH does not affect k cat or K m values for the DH reaction, a corrected value of 26 min Ϫ1 can be calculated for the ER reaction in the absence of substrate hydration. This value is still substantially smaller than k cat for the overall reaction (160 min Ϫ1 ), suggesting that the exogenous CoA moiety prevents optimal positioning of the crotonyl acyl group in the ER active site compared with the endogenous ACP carrier or that a physical step, such as product release, is rate-limiting for the reduction of crotonyl-CoA by the enzyme. The observation of a lower k cat value for crotonyl-CoA reduction by HFAS compared with the k cat value for the overall reaction prompted us to examine the chain length specificity of the ER reaction. However, as noted under "Results," C 8 -CoA and C 12 -CoA substrates were reduced with k cat values similar to or smaller than the value observed for CrtCoA. In addition, we were also curious to examine whether the endogenous pantetheine group could interfere with binding of the exogenously added substrates (28) . Consequently, we replaced Ser-2151, the point of attachment of the FAS pantetheine, with an alanine residue. A similar experiment had been reported previously by Smith and co-workers (22) in which the equivalent mutation in the rat FAS abolished the overall FAS reaction without affecting the BKR, DH, or ER partial reactions. However, in our case, although the purified S2151A HFAS enzyme was soluble and showed some ability to bind NADPH based on the fluorescence assay (see under "Results"), this enzyme showed no activity in any of the partial reactions. Consequently, in addition to acting as a substrate carrier for the overall FAS reaction, the pantetheine must also play a structural role in stabilizing the active form of the human enzyme.
Role of Lys-1699 in HFAS Catalysis-Early studies to identify catalytic residues in the reaction catalyzed by FAS utilized PLP to covalently modify lysine residues in the enzyme. These experiments demonstrated that modification of Lys-1699 selectively inhibited the ER reaction by interfering in the binding of NADPH to the ER enzyme (2, 19, 29, 30) . However, although these data localize Lys-1699 to the ER NADPHbinding site, they provide no information on the precise role of Lys-1699 in catalysis. For example, although Lys-1699 could be involved in simply binding NADPH, this residue could also have a more direct role in catalysis as exhibited by a conserved lysine residue in the SDR enzyme family (25, 32) . Consequently, we used site-directed mutagenesis to replace Lys-1699 with Ala and Gln residues, and we determined the impact of these mutations on the kinetic parameters for the FAS-catalyzed reactions.
As can be seen in TABLE THREE, mutagenesis of Lys-1699 results in a large decrease in k cat /K NADPH values for the overall reaction without affecting k cat /K MAL and k cat /K ACET values. This change in k cat /K NADPH is equivalent to a loss of 4 kcal/mol in stabilization of the rate-limiting transition state that comes after NADPH binding. In addition, because the k cat value is only modestly affected in the two mutant enzymes, Lys-1699 must also stabilize the most stable ground states after NADPH binding by around 3 kcal/mol. Thus, in agreement with the PLP labeling experiments, mutagenesis of Lys-1699 has likely affected forms of the enzyme that interact with NADPH.
The impact of the Lys-1699 mutations on the overall HFAS reaction are mirrored by similar changes to the ER reaction, implicating Lys- 1699 in both ground and transition state stabilization during substrate reduction. In the SDR family, the conserved active site lysine interacts with the NAD(P)H ribose adjacent to the nicotinamide ring and also, in some cases, hydrogen-bonds to an adjacent conserved tyrosine residue. Although Lys-1699 is not part of a consensus SDR Tyr/Lys motif, the effect of mutating Lys-1699 on the ER reaction is consistent with Lys-1699 interacting with substrates at the ER active site in a similar way to that observed for the SDR enzymes as shown in Fig. 1 . Our data are consistent with Lys-1699 occupying a position in the ER active site where it is involved in NADPH binding and can also, directly or indirectly, provide some additional stabilization to the developing enolate intermediate formed during substrate reduction. In the SDR family, the conserved active site lysine hydrogen-bonds to the NAD(P)H ribose adjacent to the nicotinamide ring and also, in some cases, interacts with the conserved tyrosine to assist in transition state stabilization (32) . We propose that Lys-1699 fulfills a similar function in HFAS, although the identity of the (putative) catalytic tyrosine has not been identified in this enzyme. In addition to effects on the overall and ER reactions, the Lys-1699 mutations also affected the BKR reaction, causing a 10-fold decrease in k cat values and a 150 -300-fold decrease in k cat /K NADPH values when acetoacetyl-CoA was the substrate. One explanation for this observation is that the BKR and ER activities share a single NADPH-binding site and that Lys-1699 fulfills a similar function in both the ER and BKR reactions. This proposal is plausible given the overall similarities in the chemistry of the ER and BKR reactions. Indeed, the structure of a type II 3-hydroxyacyl-CoA dehydrogenase provides insight into how a Tyr/Lys dyad, as suggested for the ER reaction (see above), can also function in reduction of a ␤-keto group (33) .
However, a significant amount of evidence has accumulated indicating that the ER and BKR reactions have separate NADPH-binding sites. Indeed, the original assignment of Lys-1699 to the ER enzyme was based on the observation that PLP labeling selectively inhibited the ER activity while leaving the other partial reactions unaffected. In addition, Smith and co-workers (34, 35) mutated residues in the proposed NADPHbinding sites of the ER (Gly-1672 and Gly-1673) and BKR (Gly-1886 and Gly-1888) enzymes of rat FAS, and they demonstrated that these mutations had selective effects on the two partial activities. Given the extensive data for two NADPH-binding sites, our current hypothesis is that NADPH binding to one cofactor site is sensed by the second cofactor site and, thus, that the result of mutating Lys-1699 has an allosteric effect on the BKR reaction. To shed further light on the role of Lys-1699 in NADPH binding, we studied the binding of NADPH to the free enzyme by using fluorescence spectroscopy.
NADPH Binding Studied by Fluorescence Spectroscopy-In an attempt to determine whether Lys-1699 mutagenesis has a selective effect on the interaction of NADPH with the ER cofactor site, we used fluorescence spectroscopy to analyze the interaction of wild-type and mutant HFAS with NADPH. This method has been used previously to study the interaction of NADPH with the chicken and rat FAS complexes. For chicken FAS, K d values in the low micromolar range have been reported for the two NADPH sites (11, 30, 36) . Conversely, for rat FAS no saturation with NADPH was observed up to an NADPH concentration of 16 M (35). In our case, no saturation was observed when NADPH was titrated into a solution of the wild-type HFAS enzyme up to an NADPH concentration of 20 M NADPH. Thus, similar to rat FAS, NADPH binds to the free HFAS enzyme with a K d value greater than 20 M. In addition, similar NADPH binding data were obtained for the two mutants, and thus, these data are unable to provide further insight into the interaction of Lys-1699 with NADPH.
Although our fluorescence data were unable to provide further information into the existence of one or two NADPH-binding sites in HFAS, previous studies on FAS enzymes from other sources support the proposal that the ER and BKR NADPH sites communicate allosterically. Previously, Smith and co-workers (35) quantified the interaction of NADPH with the ER and BKR enzymes in rat FAS by introducing mutations that separately compromised the binding of NADPH to each site. This method gave K d values of 4.2 and 15 M for NADPH binding to the ER and BKR cofactor binding sites, respectively. However, the data obtained for NADPH binding to the wild-type enzyme did not show evidence of a saturable component with K d ϳ4 M or other indications of biphasic behavior up to 16 M NADPH, suggesting to us that in the wild-type enzyme the ER and BKR sites are not independent of each other. In addition, Cardon and Hammes (30) observed that labeling of Lys-1699 by PLP in the chicken enzyme altered the affinity of the BKR enzyme for NADPH. Furthermore, Poulose and Kolattukudy (20) suggested that binding of NADPH to the ER enzyme was important for formation of the functional FAS dimer and that the inhibition of NADPH binding to this site by PLP labeling of Lys-1699 resulted in an effect on other activities in the FAS enzyme. Consequently, our preferred explanation for the effect of Lys-1699 mutagenesis on the ER and BKR activities reported here is that the two HFAS reductase reactions utilize distinct NADPH-binding sites, and that these two sites can communicate allosterically with each other. Because the FAS complexes are homodimers, it is possible that the ER and BKR NADPH-binding sites on separate polypeptide chains are physically close in space, providing an interface for allosteric communication. Answers to some of these questions will have to await high resolution structural data.
Conclusion-Site-directed mutagenesis has been used to investigate the role of Lys-1699 in the reaction catalyzed by HFAS. Kinetic analysis of the K1699A and K1699Q mutants reveals that Lys-1699 provides around 4 kcal/mol in transition state stabilization and 3 kcal/mol in ground state stabilization for the overall reaction catalyzed by HFAS. Similar effects on the ER partial reaction following mutation of Lys-1699 are consistent with the proposed location of this residue in the ER NADPH-binding site. However, these mutations also impact the BKR reaction. Given the large body of data supporting the presence of separate NADPH-binding sites for the ER and BKR partial activities, it is FIGURE 1. Proposed interactions of Lys-1699 with the NADPH cofactor and substrate in the ER active site. This scheme is derived from the known role of a conserved lysine in the active site of the SDR enzyme family. Lys-1699 is shown interacting with the substrate via a tyrosine residue because the SDR enzymes also utilize a conserved tyrosine in the reactions they catalyze. In addition, the hydride transfer reaction is shown occurring from the pro-(4R) NADPH hydrogen in agreement with the known stereochemistry of the ER reaction (31) .
